GSA recently notified InterFuze that we are an awardee on a U.S. Army Joint Program Executive Office (JPEO) Chemical, Biological, Radiological, Nuclear Defense (CBRND) Indefinite Delivery Indefinite Quantity (IDIQ) contract.
The purpose of this multiple-award IDIQ is to provide JPEO-CBRND and their mission partners with a contract vehicle for rapid acquisition of brand name supplies. The U.S. Army JPEO‑CBRND is the Joint Service’s leader for development, acquisition, fielding, and life-cycle support of CBRND and medical countermeasures. Their vision is a resilient Joint Force enabled to fight and win unencumbered by a chemical, biological, radiological, or nuclear environment — championed by commercial innovative and state‑of‑the-art products.
InterFuze supported the previous three iterations of this IDIQ as a small business prime, dating back to 2010. The current contract has a $500M ceiling and option years may run through 2030. We are pleased to continue our support for this mission and congratulate the other awardees for this effort.
